Tabuniag, Roselle .

HRN: 25-07-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
AMPICILLIN 1GM (VIAL)
07/13/2024
07/19/2024
IVT
2g
Q6hrs
PROM
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: